Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

File photo David Jones/PA Archive/Press Association Images

Four die after rare meningitis outbreak in US

All cases involved patients who received steroid injections for back pain, health officials said today.

AN OUTBREAK OF a rare and deadly form of meningitis has hospitalised 26 people and killed four people across five states  in America.

All the cases involved patients who received steroid injections.

Eighteen of the cases are in Tennessee where a Nashville clinic received the largest shipment of the steroid suspected in the outbreak. The drug was made by a specialty pharmacy in Massachusetts. It has since issued a recall.

Three cases have been reported in Virginia, two in Maryland, two in Florida and one in North Carolina. Two of the deaths were in Tennessee; Virginia and Maryland had one each, the Centres for Disease Control and Prevention said.

More new cases are almost certain to appear in the coming days, said Tennessee Department of Health Commissioner John Dreyzehner. Cases in that state began in July and five new cases were confirmed over the past 24 hours, he said Wednesday.

Investigators have been looking into at least three different products used for the back injections that could have been tainted by the fungus that appears to be behind the illnesses. None of the products have been ruled out. However, the primary suspicion is on steroid medication, which is commonly used for back pain.

The Food and Drug Administration identified the maker of the steroid as the New England Compounding Center, a specialty pharmacy in Framingham. Last week, the company issued a recall of three lots of the steroid. Company officials could not be immediately reached Wednesday afternoon by telephone; the company’s website was unavailable.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
16 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds